Literature DB >> 23801136

Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases.

Kazue Takai1, Koji Nikkuni, Akihito Momoi, Koichi Nagai, Natsue Igarashi, Takako Saeki.   

Abstract

We report five cases that presented with high fever, anasarca, hepatosplenomegaly and severe thrombocytopenia with reticulin fibrosis of the bone marrow. The constellation of symptoms is not compatible with any known disease, and we had difficulty in diagnosis and treatment. The age distribution was from 47 to 56 years, and two men and three women were affected. Two patients needed hemodialysis because of renal dysfunction and oliguria with massive pleural effusion. Laboratory examinations showed normal immunoglobulin levels and no monoclonal protein. None of them showed diagnostic autoantibodies for any autoimmune diseases. Histological examination of the liver in three patients and spleen in two showed non-specific findings. Lymphadenopathy was tiny and lymph node biopsy was carried out in only one case. Histologically, paracortical hyperplasia with vascular proliferation and atrophic germinal centers resembling hyaline-vascular-type Castleman's disease or POEMS syndrome were detected. Without a definitive diagnosis, treatment was started with cyclophosphamide, hydroxydaunorubicin, vincristine and prednisolone (CHOP) regimen in one patient, semi-pulse therapy with methyl-predonisolone in three and cyclosporin A in three. Two patients achieved complete remission, two were steroid-dependent and the remaining one died of multiple organ failure. These findings suggest that this disease may be a novel clinical entity belonging to systemic inflammatory disorder with a background of immunological abnormality or a unique variant of multicentric Castleman's disease. [J Clin Exp Hematop 53(1): 63-68, 2013].

Entities:  

Mesh:

Year:  2013        PMID: 23801136     DOI: 10.3960/jslrt.53.63

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  24 in total

1.  Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Authors:  Yasufumi Masaki; Hiroshi Kawabata; Kazue Takai; Masaru Kojima; Norifumi Tsukamoto; Yasuhito Ishigaki; Nozomu Kurose; Makoto Ide; Jun Murakami; Kenji Nara; Hiroshi Yamamoto; Yoko Ozawa; Hidekazu Takahashi; Katsuhiro Miura; Tsutomu Miyauchi; Shinichirou Yoshida; Akihito Momoi; Nobuyasu Awano; Soichiro Ikushima; Yasunori Ohta; Natsue Furuta; Shino Fujimoto; Haruka Kawanami; Tomoyuki Sakai; Takafumi Kawanami; Yoshimasa Fujita; Toshihiro Fukushima; Shigeo Nakamura; Tomohiro Kinoshita; Sadao Aoki
Journal:  Int J Hematol       Date:  2016-03-18       Impact factor: 2.490

2.  Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.

Authors:  Shotaro Tatekawa; Koji Umemura; Ryuichi Fukuyama; Akio Kohno; Masafumi Taniwaki; Junya Kuroda; Yoshihisa Morishita
Journal:  Clin Case Rep       Date:  2015-04-22

Review 3.  Emerging treatments in Castleman disease - a critical appraisal of siltuximab.

Authors:  Jean L Koff; Sagar Lonial
Journal:  Biologics       Date:  2016-01-25

4.  TAFRO Syndrome Associated with EBV and Successful Triple Therapy Treatment: Case Report and Review of the Literature.

Authors:  Malorie Simons; Emmanuel Apor; James N Butera; Diana O Treaba
Journal:  Case Rep Hematol       Date:  2016-09-29

5.  Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.

Authors:  Xuanye Zhang; Huilan Rao; Xiaolu Xu; Zhihua Li; Bing Liao; Hongmei Wu; Mei Li; Xiuzhen Tong; Juan Li; Qingqing Cai
Journal:  Cancer Sci       Date:  2017-12-28       Impact factor: 6.716

Review 6.  Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.

Authors:  Taku Kikuchi; Takayuki Shimizu; Takaaki Toyama; Ryohei Abe; Shinichiro Okamoto
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

Review 7.  TAFRO syndrome: current perspectives.

Authors:  Kentaro Sakashita; Kengo Murata; Mikio Takamori
Journal:  J Blood Med       Date:  2018-01-22

8.  Complete Resolution of a Case of TAFRO Syndrome Accompanied by Mediastinal Panniculitis, Adrenal Lesion, and Liver Damage with Hyperbilirubinemia.

Authors:  Shiro Ono; Kiyomi Yoshimoto; Nobushiro Nishimura; Ryo Yoneima; Hiromasa Kawashima; Tadanao Kobayashi; Yoshiaki Tai; Makiko Miyamoto; Emiko Tsushima; Noritaka Yada; Kenji Nishio
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

9.  Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.

Authors:  Tatsuya Aoki; Mikio Wada; Atsushi Kawashima; Kouichi Hirakawa; Akihiro Nagata; Keizo Kagawa
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

Review 10.  Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.

Authors:  Mari Tanaka; Hiraku Tsujimoto; Kojiro Yamamoto; Saeko Shimoda; Kazumasa Oka; Hiroya Takeoka
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.